Covington & Burling advised Ceptur Therapeutics on the deal. Ceptur Therapeutics, Inc., a biotechnology company focused on developing targeted oligonucleotide therapeutics based on U1 Adaptor technology,...
This content is for Standard 1 Year members only. LoginJoin Now